Skip to main content
SpringerLink
Log in

Skin Manifestations of the Antiphospholipid Antibody Syndrome

  • Chapter
Hughes Syndrome

Abstract

Several skin manifestations have been described in patients with antiphospholipid antibody syndrome (APS) (Table 6.1) [1–3]. The most frequent skin lesions are livedo reticularis and skin ulcers.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Battagliotti CA. Sindrome de anticuerpos antifosfolipídicos. In: Battagliotti C, Greca A et al, editors. Temas seleccionados de terapéutica clinica. UNR Editora. 1996; 328–334.

    Google Scholar 

  2. Alegre VA, Gastineau DA, Winkelmann RK. Skin lesions associated with circulating lupus anticoagulant. Br J Dermatol 1989; 120: 419–429.

    Article  PubMed  CAS  Google Scholar 

  3. Gibson GE, Daniel Su WP, Pittelkow MR. Antiphospholipid syndrome and the skin. J. Am Acad Dermatol 1997; 36: 970–982.

    Article  PubMed  CAS  Google Scholar 

  4. Tajima C, Suzuki Y, Mizushima Y, Ichikawa Y. Clinical significance of immunoglobulin A apl. Possible association with skin manifestations and small vessel vasculitis. J Rheumatol 1998; 25: 1730–1736.

    PubMed  CAS  Google Scholar 

  5. Naldi L, Locati F, Marchesi L et al. Cutaneous manifestations associated with antiphospholipid antibodies in patients with suspected primary APS: a case control study. Ann Rheum Dis 1993; 52: 219–222.

    Article  PubMed  CAS  Google Scholar 

  6. Eng AM. Cutaneous expressions of antiphospholipid syndromes. Semin Thromb Hemost 1994; 20: 71–78.

    Article  PubMed  CAS  Google Scholar 

  7. Asherson RA, Mayou SC, Merry P et al. The spectrum of livedo reticularis and anticardiolipin antibodies. Br J Dermatol 1989; 120: 215–221.

    Article  PubMed  CAS  Google Scholar 

  8. Weinstein C, Miller MH, Axtens R et al. Livedo reticularis associated with increased titers of anticardiolipin antibodies in systemic lupus erythematosus. Arch Dermatol 1987; 123: 596–600.

    Article  PubMed  CAS  Google Scholar 

  9. Sneddon JB. Cerebrovascular lesions and livedo reticularis. Br J Dermatol 1965; 77: 180–185.

    Article  PubMed  CAS  Google Scholar 

  10. Martínez Hernandez PL, Lopez Guzman A, Espinosa Arranz E, Monereo Alonso A, Arnalich Fernandez F. Sindrome de Sneddon: valor diagnostico de los anticuerpos antifosfolipídicos. Rev Clin Esp 1991; 189: 272–274.

    Google Scholar 

  11. Tourbach A, Piette JC, Iba-Zizen MT, Lyon-Caen O, Godeau P, Francés C. The natural course of cerebral lesion in Sneddon syndrome. Arch Neurol 1997; 54: 53–60.

    Article  Google Scholar 

  12. Stephens CJM. Sneddon’s syndrome. Clin Exp Rheumatol. 1992; 10: 489–492.

    PubMed  CAS  Google Scholar 

  13. Macario F, Macario MC, Ferro A, Goncalves F, Campos M, Marques A. Sneddon’s syndrome: a vascular systemic disease with kidney involvement? Nephron 1997; 75: 94–97.

    Article  PubMed  CAS  Google Scholar 

  14. Ohtani H, Imai H, Yasuda T et al. A combination of livedo racemosa, occlusion of cerebral blood vessels and nephropathy: kidney involvement in Sneddon’s syndrome. Am J Kidney Dis 1995; 26: 511–515.

    Article  PubMed  CAS  Google Scholar 

  15. Frances C, le Tonqueze M, Slohzin KV et al. Prevalence of anti-endothelial cell antibodies in patients with Sneddon’s syndrome. J Am Acad Dermatol 1995; 33; 64–68.

    Article  PubMed  CAS  Google Scholar 

  16. Rattan CE, Burton JL. Antiphospholipid syndrome and cutaneous vasoocclusive disorders. Semin Dermatol 1991; 10: 152–159.

    Google Scholar 

  17. Reyes E, Alarcon-Segovia D. Leg ulcers in the primary antiphospholipid syndrome. Report of a case with a peculiar proliferative small vessel vasculopathy. Clin Exp Rheumatol 1991; 9: 63–66.

    PubMed  CAS  Google Scholar 

  18. Leroux B, Baron E, Garrido G, Alonso A, Bergero A, Fernandez Bussy R. Vasculitis livedoide: nuestra experiencia. Dermatol Argent 1998; 2: 121–126.

    Google Scholar 

  19. Winkelman R, Schroeter A, Kierland R, Ryan T. Clinical studies of livedoid vasculitis. Mayo Clin Proc 1994; 49: 746–750.

    Google Scholar 

  20. Kern A. Atrophie blanche. J Am Acad Dermatol 1982; 6: 1048–1053.

    Article  PubMed  CAS  Google Scholar 

  21. Stephansson EA, Niemp KM, Jouikainen T, Vaarala O, Polosue T. Lupus anticoagulant and skin. Acta Dermato Venereol 1991; 71: 416–422.

    CAS  Google Scholar 

  22. Hassan ML, Di Fabio NA, Martinez Aquino E, Schroh R, Kien C, Magnin PH. Vasculitis livedoide. Estudio clínico, histopatológico y laboratorial de 10 casos. Rev Arg Derm 1987; 68: 311–319.

    Google Scholar 

  23. Dodd HJ, Sarkany I, O’Shayghnessy D. Widespread cutaneous necrosis associated with lupus anticoagulant. Clin Exp Dermatol 1985; 10: 581–586.

    Article  PubMed  CAS  Google Scholar 

  24. Asherson RA, Jacobelli S, Rosemberg H, McKee P, Hughes GRV. Skin nodules and macules resembling vasculitis in the antiphospholipid syndrome–a report of two cases. Clin Exp Dermatol 1992; 17: 266–269.

    Article  PubMed  CAS  Google Scholar 

  25. Alegre VA, Winkelmann RK. Histopathologic and immunofluorescence study of skin lesions associated with circulating lupus anticoagulant. J Am Acad Dermatol 1988; 19; 117–124.

    Article  PubMed  CAS  Google Scholar 

  26. Martinovic Z, Perisic K, Pejnovic N, Lukacevic S, Rabrenovic L, Petrovic M. Antiphospholipid antibodies in inflammatory bowel diseases. Vojnosanit Pregl 1998; 55: 47–49.

    PubMed  CAS  Google Scholar 

  27. Mevorach D, Goldberg Y, Gomori JM, Rachmilewitz D. Antiphospholipid syndrome manifested by stroke in a patient with Crohn’s disease. J Clin Gastroenterol 1996; 22: 141–143.

    Article  PubMed  CAS  Google Scholar 

  28. Asherson RA, Cervera R, Piette JC, Font J, Lie JT, Burcoglu A et al. Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients. Medicine 1998; 77: 195–207.

    Article  PubMed  CAS  Google Scholar 

  29. Lockshin MD. Which patients with antiphospholipid antibody should be treated and how? Rheum Dis Clin NA 1993; 19: 235–251.

    CAS  Google Scholar 

  30. Derksen RH, De Groot PH, Kater L et al. Patients with antiphospholipid antibodies and venous thrombosis should receive lifelong anticoagulant treatment. Clin Exp Rheumatol 1992; 10: 662–668.

    Google Scholar 

  31. Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GRV. The management of thrombosis in the antiphospholipid antibody syndrome. N Engl J Med 1995; 332: 993–997.

    Article  PubMed  CAS  Google Scholar 

  32. Curwin J, Kyung Jang I, Fuster V. Expanded use of thrombolytic therapy. Mayo Clin Proc 1992; 332: 993–997.

    Google Scholar 

  33. Klein KL, Pittelkow MR. Tissue plasminogen activator for treatment of livedoid vasculitis. Mayo Clin Proc 1992; 67: 923–933.

    Article  PubMed  CAS  Google Scholar 

  34. Gertner E, Lie JT. Systemic therapy with fibrinolytic agents and heparin for recalcitrant nonhealing cutaneous ulcer in the antiphospholipid syndrome. J Rheumatol 1994; 21: 2159–2161.

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. C. A. Battagliotti
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Lupus Research Unit, St Thomas’ Hospital, Lambeth Palace Road, SE1 7EH, London, UK

    M. A. Khamashta MD, MRCP, PhD (Deputy Head) (Deputy Head)

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer-Verlag London

About this chapter

Cite this chapter

Battagliotti, C.A. (2000). Skin Manifestations of the Antiphospholipid Antibody Syndrome. In: Khamashta, M.A. (eds) Hughes Syndrome. Springer, London. https://doi.org/10.1007/978-1-4471-3666-8_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-3666-8_6

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-85233-232-7

  • Online ISBN: 978-1-4471-3666-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation